Sign in

Regulatory Submission Readiness Platform

AI governance and submission-readiness platform for pharmaceuticals and biotech, supporting regulator-aligned model credibility, lifecycle risk assessment, HTA-adapted evidence synthesis, compliant training, and accelerated dossier authoring.

The Problem

“Pharma AI governance and submission readiness are fragmented, manual, and slow across regulatory, HTA, training, and dossier workflows”

Organizations face these key challenges:

1

AI governance decisions are inconsistent across functions and jurisdictions

2

Model credibility and lifecycle risk assessments are difficult to document and update

3

HTA bodies require localized comparative value evidence beyond core regulatory submissions

4

Medical writing teams spend excessive time assembling and reconciling source content

Impact When Solved

Reduce dossier authoring cycle time by 30-60% through source-grounded draft generation and review workflowsStandardize AI risk assessment across development, quality, safety, and regulatory functionsImprove HTA readiness with region-specific comparative evidence synthesis and traceable referencesIncrease training effectiveness with automatically generated, procedure-aligned assessments

The Shift

Before AI~85% Manual

Human Does

  • •Collect AI use cases, policies, SOPs, and source documents across functions
  • •Assess model risk, credibility, and submission readiness through manual committee review
  • •Search literature and compile region-specific HTA evidence tables and narratives
  • •Draft dossier sections and training assessments from prior materials and approved sources

Automation

  • •No meaningful AI support; teams rely on spreadsheets, static documents, and manual comparisons
  • •Basic document search or template reuse without structured risk scoring or evidence synthesis
  • •Limited automation for formatting, copyediting, and administrative tracking
With AI~75% Automated

Human Does

  • •Approve AI risk classifications, required controls, and governance decisions
  • •Review and sign off HTA evidence summaries, dossier drafts, and training assessments
  • •Resolve policy conflicts, jurisdiction-specific exceptions, and high-risk use cases

AI Handles

  • •Classify AI use cases, score lifecycle risk, and generate submission-readiness checklists
  • •Retrieve and synthesize approved evidence into region-specific HTA tables and comparative narratives
  • •Generate source-grounded dossier draft sections with section-level provenance and traceability
  • •Create procedure-aligned training exams, answer keys, and rationales from approved materials

Operating Intelligence

How Regulatory Submission Readiness Platform runs once it is live

Humans set constraints. AI generates options.

Humans choose what moves forward.

Selections improve future generation quality.

Confidence89%
ArchetypeGenerate & Evaluate
Shape6-step branching
Human gates2
Autonomy
50%AI controls 3 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapebranching

Step 1

Define Constraints

Step 2

Generate

Step 3

Evaluate

Step 4

Select & Refine

Step 5

Deliver

Step 6

Feedback

AI lead

Autonomous execution

2AI
3AI
5AI
gate
gate

Human lead

Approval, override, feedback

1Human
4Human
6↺ Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

Humans define the constraints. AI generates and evaluates options. Humans select what ships. Outcomes train the next generation cycle.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in Regulatory Submission Readiness Platform implementations:

HTA-specific dataOther
4 mentions
Local healthcare cost dataOther
4 mentions
Regulator-developed ASLMsOther
4 mentions
Fine-tuningOther
3 mentions
Real-world evidenceOther
3 mentions
+3 more technologies(sign up to see all)

Key Players

Companies actively working on Regulatory Submission Readiness Platform solutions:

ArisGlobalGeneric evidence synthesis toolsGxP compliance software vendorsInternal HTA analytics workflowsInternal quality and AI governance programs
+3 more companies(sign up to see all)

Real-World Use Cases

AI in pharmaceutical manufacturing within the medicine lifecycle

Use AI to improve how medicines are made, while keeping the process safe and acceptable to regulators.

Optimization and process monitoringproposed under shared principles and likely to expand as jurisdiction-specific guidance matures
10.0

Accelerated dossier authoring with generative AI

AI helps write parts of regulatory dossiers faster, giving teams a head start on submission documents instead of drafting everything from scratch.

content generation + synthesis from source materialspoc / emerging
10.0

HTA-adapted AI for regional evidence synthesis and relative effectiveness assessment

Take a trial-design AI built by regulators and adapt it with local cost and real-world healthcare data so health assessment agencies can judge how useful and cost-effective a treatment is in their own system.

Contextual evidence synthesis and comparative evaluation.early-stage but structurally well-defined; the article lays out a three-step implementation path from regulators to htas to end users.
10.0

AI-assisted medicinal product lifecycle decision support

Use AI tools to help people make sense of large amounts of medicine-related data across development, manufacturing, and safety monitoring.

Decision support and pattern extraction from heterogeneous lifecycle dataproposed and actively reflected on by regulators, not presented in the source digest as a single mature deployed system.
9.5

Generative AI exam creation for operator training in AI-enabled quality control

An AI tool helps companies quickly make better quizzes so workers actually understand the rules and systems they use.

content generation and assessment authoringbeta-stage product use case with clear practical workflow and customer feedback signal.
9.5

Free access to this report